Anagram & Information om | Engelska ordet LCH

Exempel på hur man kan använda LCH i en mening

• The LCH will also have forward-looking infrared (FLIR), a charge-coupled device (CCD) camera, and a target acquisition system with laser rangefinder and thermal vision.
• Langerhans cell histiocytosis (LCH) is an abnormal clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes.
• Regardless of the subtype of Langerhans cell histiocytosis, the pathologic hallmark for all subtypes of LCH is the abnormal proliferation and accumulation of immature Langerhans cells, macrophages, lymphocytes, and eosinophils.
• Diagnosis can often be difficult because of the rareness of ECD as well as the need to differentiate it from LCH.
• By March 2016, the LCH had reportedly completed basic performance flight testing and outstation trials, including a number of live-fire tests involving prototype TD-3 firing 70 mm rockets in its weaponized configuration.
• For the purpose of contract negotiations, short cars were referred to as SCH, SH or STH and long as LCH, LH or LTH, respectively for conductor, regular and terminal carriages.
• Non-Langerhans cell histiocytosis, also known as rare histiocytoses, comprise all histiocyte, macrophage, and dendritic cell proliferative disorders that are not categorized as hemophagocytic lymphohistiocytosis (HLH) or Langerhans cell histiocytosis (LCH).
• Destinations served on a nonstop basis from IAH by this Eastern Express service included Beaumont/Port Arthur, TX (BPT); Clear Lake City, TX (CLC), Lake Charles, LA (LCH); Longview, TX (GGG); Sugar Land, TX (SGR); Tyler, TX (TYR); and Victoria, TX (VCT).
• Indeterminate cell histiocytosis (LCH) is an uncommon proliferative illness where the predominant cells have characteristics from both non-Langerhans cell histiocytosis (NLCH) and Langerhans cell histiocytosis (LCH) in terms of morphology and immunophenotypic characteristics.
• 1996 – Majority ownership of LCH transfers to the whole clearing membership, with the LME, IPE and LIFFE acquiring minority ownership.
• Under his leadership, the London Stock Exchange Group acquired MillenniumIT (2009), Turquoise Holdings Ltd (2010), FTSE Group (2011), TRS (2011), GATElab Srl (2012), EuroTLX Srl (2013), LCH.
• He is particularly noted for his pioneering work in the study and treatment of histiocytic disorders, especially Langerhans Cell Histiocytosis (LCH).

Förberedelsen av sidan tog: 1 046,33 ms.